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epidemics in many parts of the world. Aedes and Culex mosquitoes are the main culprits, spreading 23 infection when they bite. Importantly, mosquitoes do not act as simple conduits that passively 24 transfer virus from one individual to another. Instead, host responses to mosquito-derived factors 25
have an important influence on infection and disease, aiding replication and dissemination within 26 the host. Here, we discuss the latest research developments regarding this fascinating interplay 27 between mosquito, virus and the mammalian host. 28
Arboviruses are genetically highly diverse and represent one of the largest virus groups, with 48 more than 600 members, of which at least 80 are known human pathogens [9] . Most medically 49 important arboviruses transmitted by mosquitoes are found in three distinct families; Flaviviridae, 50 which includes dengue (DENV), Zika (ZIKV), yellow fever (YFV), and West Nile (WNV) viruses; 51 Togaviridae, which includes chikungunya (CHIKV), Semliki Forest (SFV) and Venezuelan equine 52 encephalitis (VEEV) viruses; and Bunyaviridae, which includes La Crosse virus. Depending on the 53 virus, infection can result in a diverse range of severe manifestations that include arthritis, 54 encephalitis, or vascular leakage leading to shock [10] [11] [12] . This heterogeneity, combined with our 55 inability to accurately predict the nature and timing of future epidemics, makes developing and 56 stockpiling virus-specific drugs and vaccines very challenging [13] . 57 disseminate from skin and cause disease, although mosquito bites do accelerate their pathogenesis 117 [16, 22] . However, these virulent strains, which are consistently lethal in mice, do not model natural 118 human arbovirus infection particularly well, as human mortality is low for most arboviruses. Taken  119 together, these studies demonstrate that genetically distinct arboviruses make use of common 120 mosquito-derived factors to augment their transmission to, and replication within, the mammalian 121 host. Although viruses have co-evolved with the blood feeding strategies of their arthropod vectors, 122 it is not yet clear if bite enhancement of infection is serendipitous or an evolved strategy on the 123 part of the virus. Either way, an appreciation of how arthropods modulate cutaneous responses to 124 infection is crucial for understanding arbovirus transmission and pathogenesis. 125
126

Cutaneous immune response to mosquito bites and arbovirus infections 127
To determine how mosquito bites enhance virus infection, we first need to consider separately how 128 the skin responds to bites and to virus infection. Natural infection with arboviruses elicits at least 129 three distinct host responses: to bite trauma, to mosquito saliva and to virus. Here, we summarize 130 the current knowledge about early cutaneous immune responses to mosquito bites and mosquito 131 saliva and how this differs from host responses to virus infection. 132
133
Cutaneous responses to mosquito bites 134
While seeking a blood meal, mosquitoes probe for blood vessels in the dermis with their probiscus, 135 continuously depositing saliva, and imbibe blood once a blood vessel is pierced [14, 31] . Saliva 136 contains many biologically active components, including molecules that enhance leukocyte influx 137 [16, 21, 32, 33] , and in addition contains a complex bacterial microbiota [34] that may also be 138 inflammatory [35] . Trauma associated with arthropod bites induces local inflammation, and salivary 139 protein(s) activate immune processes locally and possibly more distally in the draining lymph node 140 [33, 36, 37] . 141
142
Chemokine-mediated recruitment of leukocytes to mosquito bites. Mosquito bites elicit a rapid 143 cutaneous response that includes expression of cytokines [16, 36] and degranulation of mast cells 144
[38]. Inflammatory chemokines (chemotactic cytokines) are expressed at sites of damage or 145 infection and control the entry and positioning of leukocytes within tissues [39] . Chemokines that 146 attract neutrophils are expressed particularly highly following a bite, resulting in a rapid influx of 147 these cells [16, 21, 37, 38] . In other models of inflammation, neutrophils have been shown to 148 undertake a range of important anti-microbial functions and promote the influx of additional 149 leukocytes [40] . Following a mosquito bite, mast cell degranulation may be a necessary first step 150 mediating neutrophil recruitment, as mast cell-deficient mice failed to upregulate the key 151 neutrophil chemoattractant CXCL2 [36] . Bite-infiltrating neutrophils express high levels of the key 152 pro-inflammatory cytokine IL-1 and are important for coordinating inflammatory responses, as 153 neutrophil-deficient mice exhibit significantly reduced expression of some innate immune genes in 154 the skin, including chemokines that attract CCR2-expressing inflammatory myeloid cells [16] , some 155 of which can differentiate into dendritic cells (DCs) [21] . Mosquito biting and SGE can also induce 156 the expression of T-cell associated cytokines, most notably 41] . In summary, mosquito 157 bites induce a multi-step recruitment of leukocytes that begins with mast cell degranulation and 158 neutrophil recruitment, followed by an influx of monocytes. 159
Considerable insight into host responses to arthropod saliva has also been gained by 160 studying tick feeding [32] . In contrast to mosquitoes, ticks spend many days probing the skin and 161 preparing the bite site. The prolonged feeding time and associated risk of immune rejection of ticks 162 has driven the evolution of a powerful set of molecules to suppress host immunity. Tick saliva has 163 numerous immunomodulatory properties, including those that blunt chemotactic responses via a 164 family of proteins called Evasins [42, 43] . Evasins bind with high affinity to inflammatory 165 chemokines, thus functioning as highly effective suppressors of leukocyte recruitment. In 166 comparison, there is no evidence that mosquitoes express salivary proteins with similar immune-167 suppressing activity. 168
169
Mosquito saliva promotes extensive cutaneous edema. The swelling associated with a mosquito bite 170 is an obvious symptom; however, the mechanisms involved are still poorly defined. Quantification 171 of bite edema by measuring the extent of plasma leakage into the skin has demonstrated that 172 edema is both rapid and robust [16, 21] . Mosquito saliva contains components that facilitate 173 efficient blood feeding, including vasodilation of blood vessels and inhibition of blood clotting 174 [32, 44] . Importantly, SGE in the absence of bite trauma can not only induce endothelial 175 permeability in the skin of mouse ears, but can also directly disrupt the barrier function of human 176 endothelial cells in vitro in the absence of virus or other cell types [21] . In addition to these direct 177 effects, mosquito probing also causes tissue trauma and inflammation. This includes histamine 178 release from mast cells [38] for example, deposit >99% of WNV into the skin at a median dose of 10 5 plaque forming units, 208 while the 0.1% of virus that directly enters the bloodstream is rapidly inactivated or cleared [14] . 209
Following infection with SFV, the majority of virus in the blood by 24 hours was derived from the 210 inoculation site and draining lymph node [16] . Furthermore, the importance of viral replication at 211 the mosquito bite site for dictating the subsequent systemic course of infection has also been 212 demonstrated by studies that have surgically removed this site post-inoculation, e.g., for St. Louis such as SFV or WNV [16, 64] . Together, these data suggest a biphasic role of neutrophils in arbovirus 235 pathogenesis, initially contributing to virus replication and spread and later supporting virus 236
clearance. 237
Monocytes are innate immune cells found in the blood that are recruited to sites of inflammation 238 via signals that primarily involve the chemokine receptor CCR2 [65] . DENV and WNV infection in the 239 skin leads to the recruitment of monocytes to the dermis and differentiation to monocyte-derived 240
DCs. DENV can replicate in dermal monocytes and DCs [55] [56] [57] 66] , while a variety of arboviruses can 241 replicate in DCs [52, 54, 56, 67, 68] . The effect that DC infection by arboviruses has on the systemic 242 course of infection is currently a matter of active research (see text box 4). 243
How do mosquito bites enhance arbovirus infection? 244
Mosquito bites and the saliva that is deposited in the skin may enhance arbovirus infection through 245 a number of mechanisms, including host inflammatory responses to mosquito bites [16] ; saliva-246 induced edema [16, 21] ; enzymatic activity of saliva components [26] ; and immune 247 suppression/subversion by saliva [28, 37, 41, 69] . 248
Inflammatory responses to mosquito bites augment arbovirus infection. Host inflammatory 249
responses to mosquito bites have been shown to have a defining effect on the systemic course and 250 clinical outcome of SFV or bunyamwera virus infection [16] . Bite-recruited neutrophils coordinate a 251 cutaneous inflammatory response that facilitates the entry of inflammatory myeloid cells. Some of 252 these infiltrating cells and skin-resident macrophages become infected and generate infectious 253 virus progeny. In the absence of CCR2-dependent inflammatory myeloid cell influx, bites were 254 unable to enhance virus infection [16] . Suppression of bite inflammation by therapeutic depletion 255 of neutrophils or by inhibition of the IL-1 pathway was also able to suppress bite enhancement of 256 virus infection. Interestingly, structurally unrelated pro-inflammatory molecules that induce gene 257 expression profiles similar to bites (e.g., supportive of early neutrophil influx and absence of type I 258 IFNs) were also able to enhance SFV infection [16] . As such, bite-induced inflammation may be an 259 attractive target for strategies that aim to prevent or limit arbovirus infection, as they constitute a 260 common element of all mosquito-borne infections. It will be important to determine whether these 261 findings, which primarily used model arboviruses in mice, also apply to human pathogens. 262
Along the same lines, significant insights have emerged from studies using DENV and SGE 263 that parallel the findings with SFV [21, 55] hosts. The local response to the mosquito bite, which includes increased vascular permeability, 307 edema, inflammation and recruitment of virus-susceptible cells, unwittingly promotes a beneficial 308 niche for arbovirus replication [16, 21] . This profound enhancing effect on initial viral replication and 309 subsequent dissemination underlines the need to use models that incorporate mosquito-derived 310
factors. 311
Many aspects of the early immune response in the skin to mosquito bites and arbovirus infection 312 remain poorly understood. Nonetheless, it is becoming clear that targeting common denominators 313 could be a promising novel strategy to limit infection with multiple arboviruses. Improved 314 understanding of cutaneous immune responses will aid the identification of such targets. Possible 315 strategies include targeting the immune pathways that are inadvertently beneficial for arboviruses, 316 such as recruitment of additional susceptible cells, or improving the antiviral response in the skin. 317
Pan-viral treatments would be particularly beneficial in regions where multiple arboviruses circulate 318 concurrently, especially as it is hard to determine which virus is being most commonly transmitted; 319 patients are diagnosed based on clinical symptoms that are often overlapping for distinct viruses 320
[72]. In addition, lab-based diagnostics are either absent or take too long to meaningfully impact 321 case management, particularly in resource-poor settings. We suggest that it is now appropriate to 322 explore whether vaccines or medicines that either target common mosquito-sourced factors or 323 common aspects of viruses can be protective/efficacious. One such approach could involve vaccines 324 that target mosquito saliva components. Mosquitoes have evolutionary diverged from their last 325 common ancestor in their Nematocera suborder over 100 million years ago, resulting in at least 76 326 families of salivary genes of which most are species specific, such as those that have evolved to 327 inhibit blood clotting [73] 
Local immune response after transmission of virus with mosquito saliva into the dermis. 342
Mosquito saliva and virus trigger mast cell degranulation (1), which increases the permeability of 343 blood vessels (2) and leads to leakage of plasma into the skin that causes edema (3). The virus first 344 infects stromal cells (such as fibroblasts) as well as dendritic cells (DCs) or macrophages (Ms) that 345 reside in the dermis (4). Mosquito bite trauma, saliva, and infection induce inflammation that leads 346 to the recruitment of neutrophils (5), which secrete additional attractants to recruit monocytes (6). 347
Monocytes differentiate to inflammatory DCs and Ms that can become targets for a second wave 348
of virus infection (7). At the same time, resident dermal DCs migrate along lymphatic vessels to 349 skin-draining lymph nodes to induce adaptive immune responses (8). Also, virus rapidly drains to 350 lymph nodes (9). This virus dissemination may be accelerated via the saliva-induced plasma leakage 351 into the skin and contribute to exacerbation of disease severity (10) [89]. Perhaps more important is the observation that passage of the malarial parasite through 376 mosquitoes appears to attenuate virulence in mice. In this study, mosquitoes were shown to 377 modify the biology of the parasite, resulting in altered mammalian host immune responses to 378 infection that rendered the infection less virulent [90] . [16, 24] . However, the 401 cellular and molecular basis by which they are activated and coordinated in the skin is not well 402
understood. 403 404
Text box 4. Dissemination of virus from skin to draining lymph nodes 405
The mechanism by which arbovirus disseminates to draining lymph nodes is currently the subject 406 of research and debate. Virus may disseminate from the skin as free virus in lymph fluid, or 407 alternatively may also disseminate within infected cells, such as DC which are highly migratory. 408
Dermal DCs act as sentinels of infection and migrate from the skin to draining lymph nodes when 409 activated by inflammation or infection, including infection with arboviruses [102, 103] . Arbovirus 410 infection of dermal DCs could lead to amplification of virus, suppress priming of adaptive immune 411 responses, and/or facilitate virus dissemination to draining lymph nodes as they migrate. In the 412 case of DENV infection of mouse skin, infected DC migrate to the draining lymph node [56] . 
